An in vitro evaluation of the potential suitability of peripheral blood CD14+ and bone marrow CD34+-derived dendritic cells for a tolerance inducing regimen in the primate

被引:14
作者
Ashton-Chess, J
Blancho, G
机构
[1] CHU Nantes, Hotel Dieu, INSERM, U437, F-44093 Nantes, France
[2] CHU Nantes, Hotel Dieu, Inst Transplantat & Rech Transplantat, F-44093 Nantes, France
关键词
dendritic cells; immunotherapy; transplantation; tolerance; baboon;
D O I
10.1016/j.jim.2004.12.012
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DC) represent a tool not only for immune activation, but also potentially for tolerance induction in transplantation. This latter approach is yet to be explored in a pre-clinical primate model. Since no information concerning baboon DC has been available, we characterised the DC of this species derived in vitro from bone marrow (CD34+) and peripheral blood (CD14+) precursors to determine which would be the most suitable for a tolerance inducing strategy. Baboon DC were differentiated in vitro using protocols similar to those used in humans and their maturation status was assessed and compared according to their phenotype and function. Based on both phenotypic and functional criteria, the CD14-derived baboon DC appeared to be less mature DC, necessitating an additional stimulus in order to become fully mature. The CD34-derived DC on the other hand appeared more mature in nature, without necessarily requiring exposure to overt maturation signals. We suggest therefore that, in the baboon, peripheral blood CD14-derived DC may be more suitable for protocols where tolerance induction is the goal. We now aim to perform further in vitro investigations into the potential tolerance inducing effects of CD14-derived DC alone or in association with other strategies that would be applicable in vivo. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:237 / 252
页数:16
相关论文
共 38 条
[1]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[2]   Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboon [J].
Boulday, G ;
Ashton-Chess, J ;
Bernard, P ;
Karam, G ;
Vié, H ;
Moreau, A ;
Minault, D ;
Lorré, K ;
Soulillou, JP ;
Blancho, G .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (07) :1752-1760
[3]   Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cell sin allograft tolerance by LF15-0195 treatment [J].
Chiffoleau, E ;
Bériou, G ;
Dutartre, P ;
Usal, C ;
Soulillou, JP ;
Cuturi, MC .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :5058-5069
[4]   Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans [J].
Dhodapkar, MV ;
Steinman, RM .
BLOOD, 2002, 100 (01) :174-177
[5]   Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells [J].
Dhodapkar, MV ;
Steinman, RM ;
Krasovsky, J ;
Munz, C ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :233-238
[6]   Electron microscopy study of intrahepatic ultrasmall superparamagnetic iron oxide kinetics in the rat. Relation with magnetic resonance imaging [J].
Dupas, B ;
Berreur, M ;
Rohanizadeh, R ;
Bonnemain, B ;
Meflah, K ;
Pradal, G .
BIOLOGY OF THE CELL, 1999, 91 (03) :195-208
[7]   CD40 ligation on human cord blood CD34(+) hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells [J].
FloresRomo, L ;
Bjorck, P ;
Duvert, V ;
vanKooten, C ;
Saeland, S ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (02) :341-349
[8]   Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80(dim), CD86(-)) prolong cardiac allograft survival in nonimmunosuppressed recipients [J].
Fu, FM ;
Li, YP ;
Qian, SG ;
Lu, LN ;
Chambers, F ;
Starzl, TE ;
Fung, JJ ;
Thomson, AW .
TRANSPLANTATION, 1996, 62 (05) :659-665
[9]  
Gagne K, 2001, EUR J IMMUNOL, V31, P3111, DOI 10.1002/1521-4141(2001010)31:10<3111::AID-IMMU3111>3.0.CO
[10]  
2-6